Categorías
- Instrumentos
- Agitadores / Agit. Incubadores
- Orbitales
- Con Incubación
- Incubadores Gran Capacidad
- Lineales, Balanceo y 3D
- Incubadores Microplacas
- Para colocar en estufa
- Magnéticos
- Mezcladores /Roller /Rotatorios
- Agitadores de Paletas
- Jeio Tech Accesorios para Agitadores
- Benchmark Accesorios para Agitadores
- N-Biotek Accesorios para Agitadores
- Biosan Accesorios para Agitadores
- Labnet Int. Accesorios para Agitadores
- Vórtex
- Analisis Imagen, animales, plantas, geles
- Balanzas
- Baños Termostáticos
- Cabinas Flujo / Extraccion gases / PCR
- Centrifugas
- Detectores de Radioactividad
- Electroforesis
- Electroquímica
- Equipos Microplacas
- Espectrofotometros
- Experimentacion Animal
- Hornos de Hibridacion
- Homogeneizadores
- Estufas / Equipos calor, frio
- Luminómetros de Tubos
- Microbiologia
- Pipetas / Dispensadores
- Pipetas Labnet Int. Monocanales Automaticos
- Pipetas HTL Monocanales Automáticas
- Pipeta Accumax Mono y Multicanales
- Pipetas Labnet Int. Multicanales
- Pipetas HTL Multicanales
- Pipetas Volumen Fijo
- Pipetas Electrónicas
- Dispensadores
- Dispensadores de Botella
- Pipetas Biosan Monocanales
- Pipetas Biosan Multicanales
- PCR / Tiempo Real (qPCR)l / Cicladores
- QPCR, Sistemas automaticos
- Sonicadores / Ultrasonidos
- Ultracongeladores
- Bombas Jeringa / Vacio / Osmoticas
- Ultracentrífugas
- Micro Array label free
- Contadores de Células
- Contenedores Criogenicos
- Producción agua ultrapura
- Electrospinning
- Agitadores / Agit. Incubadores
- Reactivos
- Consumibles
- Catálogos PDF
Listado de productos por fabricante AbMole
Trelagliptin
Trelagliptin (SYR-472) is a novel once-weekly oral DPP-4 inhibitor for type 2 diabetes.
Trelagliptin
Trelagliptin (SYR-472) is a novel once-weekly oral DPP-4 inhibitor for type 2 diabetes.
Trelagliptin
Trelagliptin (SYR-472) is a novel once-weekly oral DPP-4 inhibitor for type 2 diabetes.
Trelagliptin
Trelagliptin (SYR-472) is a novel once-weekly oral DPP-4 inhibitor for type 2 diabetes.
Trelagliptin succinate
Trelagliptin(SYR-472) succinate is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).
Trelagliptin succinate
Trelagliptin(SYR-472) succinate is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).
Trelagliptin succinate
Trelagliptin(SYR-472) succinate is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).
Trelagliptin succinate
Trelagliptin(SYR-472) succinate is a long acting dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D).
Tremelimumab
Tremelimumab (Ticilimumab) is a fully humanized monoclonal antibody specific for cytotoxic T-lymphocyte antigen-4 (CTLA-4) and can be used for metastatic melanoma research.
Tremella polysaccharide
Tremella polysaccharide is an acidic heteropolysaccharide prepared from the fruit body of Tremella fuciformis Bark (Tremella fuciformis Bark) or submerged culture mycelium and fermentation broth, can be used as adjuvant.
Tremella polysaccharide
Tremella polysaccharide is an acidic heteropolysaccharide prepared from the fruit body of Tremella fuciformis Bark (Tremella fuciformis Bark) or submerged culture mycelium and fermentation broth, can be used as adjuvant.
Tremella polysaccharide
Tremella polysaccharide is an acidic heteropolysaccharide prepared from the fruit body of Tremella fuciformis Bark (Tremella fuciformis Bark) or submerged culture mycelium and fermentation broth, can be used as adjuvant.